|
Volumn 22, Issue 2, 2002, Pages 104-106
|
Influence of combined therapy of guben yiliu III, moxibustion and chemotherapy on immune function and blood coagulation mechanism in patients with mid-late stage malignant tumor
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
CE CAP PROTOCOL;
CE-CAP PROTOCOL;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
ETOPOSIDE;
FAM PROTOCOL;
FLUOROURACIL;
HERBACEOUS AGENT;
MITOMYCIN;
ARTICLE;
BLOOD;
BLOOD CLOTTING;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
HUMAN;
IMMUNOLOGY;
LUNG TUMOR;
LYMPHOCYTE COUNT;
MALE;
MOXIBUSTION;
PHYTOTHERAPY;
RANDOMIZED CONTROLLED TRIAL;
STOMACH TUMOR;
T LYMPHOCYTE SUBPOPULATION;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BLOOD COAGULATION;
CARBOPLATIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
DRUGS, CHINESE HERBAL;
ETOPOSIDE;
FEMALE;
FLUOROURACIL;
HUMANS;
LUNG NEOPLASMS;
LYMPHOCYTE COUNT;
MALE;
MITOMYCIN;
MOXIBUSTION;
PHYTOTHERAPY;
STOMACH NEOPLASMS;
T-LYMPHOCYTE SUBSETS;
|
EID: 0038282490
PISSN: 10035370
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (13)
|
References (0)
|